Your address will show here +12 34 56 78
Congress

As every year the meeting is divided in three days. There will be much discussion on hot topics and trends in areas of Endocrine surgery, the papillary thyroid cancer, the quality approach in thyroid surgery. It is with great delight and motivation that our team will be presented during all this congress. We would be pleased to exchange with you about on the available applications of our new device, the FLUOBEAM® LX on our stand.

0

Congress

FLUOPTICS© is a French company which develops innovative solutions of imaging by fluorescence to guide in real time the surgeon during the operative act.This year FLUOPTICS© will be present to propose you our new device,the FLUOBEAM® LX system, which is dedicated to thyroid and parathyroid surgery. This device is the only one on the market to propose an application allowing to visualize parathyroid glands by autofluorecence and their perfusion. Our application engineers wait for you on our booth to exchange with you in more detail.

0

Congress

Main association of endocrine surgery in North America, the American Association of Endocrine Surgeons organizes his 39th congress in Los Angeles. As every year FLUOPTICS© will be present to propose you our device, FLUOBEAM®. This device is the only one on the market to propose an application allowing to visualize parathyroid glands by autofluorecence and their perfusion. Our application engineers wait for you on our booth to exchange with you in more detail.

0

Press & Media

Last November FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery.
It is a recognition of the performance of the FLUOBEAM® and for the development of fluorescence imaging.
Today, we are highlighted in the Presences revue of the Grenoble CCI for this market authorization.
For more information, please click on the link Présences_CCI de Grenoble.

0

Press & Media

FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery. The FLUOBEAM® Imaging System becomes the first and unique system certified for this indication.
The FLUOBEAM® provides, earlier, real-time location of parathyroid tissue during surgical procedures such as thyroidectomy (surgery to remove all or part of the thyroid) and parathyroidectomy (surgery to remove one or more parathyroid glands). The early detection of theses glands allows reduces postoperative hypocalcemia.
It is a recognition of the performance of the FLUOBEAM® and for the development of fluorescence imaging.

0

Congress

As every year, the surgical association of endocrinology, CAEK, gathered to exchange on various themes of the endocrinology, the scientific discoveries in molecular biology and the cooperation between different medical specialization. This 37th congress will study the current results of endocrine surgery theses and also on the clinical and scientific questions of the patient prognosis and his quality of life for thyroid surgery, the parathyroid glands, adrenal and pancreatic.
For this congress we shall be delighted to meet you on our booth to present to you our FLUOBEAM® that you could test. Be the first to discover our latest application dedicated to the thyroid and parathyroid glands surgery.

0